Lab automation to optimise data processing and maximise throughput
This advertorial for Tecan appeared in DDW Volume 26 – Issue 1, Winter 2024/25 Read the digital issue
Digital tools and walkaway time allow scientists to accelerate their research, says Mukta Acharya, Head of Life Sciences Business Division, Tecan.
Life sciences are experiencing a transformative wave of automation, artificial intelligence (AI) and robotics, projected to nearly double its global market from $5.4 billion in 2023 to $9.5 billion by 20331.
These technologies streamline lab processes, enhancing productivity, throughput and data precision. Automated solutions, such as liquid handling systems, enable reproducible workflows, freeing scientists to focus on innovation rather than repetitive tasks.
The drive for automation in drug development maximising walkaway time
Drug development laboratories continue to invest in digital transformation. Companies are modernising their laboratories with an increasing amount of revenue allocated to automation.
Benefits include reduced errors, consistent results, higher regulatory approval rates, optimised costs and faster time-to-market. Automation extends beyond liquid handling to technologies like next-generation sequencing (NGS), proteomics and lab-on-a-chip innovations, creating labs ready for the complexities of future research.
Automation reduces manual workloads, allowing scientists to concentrate on tasks that require their expertise. “Not having to perform manual tasks like pipetting but instead focusing on research increases walkaway time,” says Victoria Herschel, Applications Team Manager at Tecan.
Automated systems enhance consistency and throughput, enabling researchers to explore a wider range of experimental conditions efficiently. Remi Magnan, Head of Application Solutions and Innovation at Tecan, highlights the impact: “Automation allows drug discovery labs to produce more consistent results. What took days manually can be achieved in hours.” For instance, one Tecan client expanded their biologics collection tenfold while reducing staffing needs, thanks to optimised workflows incorporating task such as barcoding and temperature controls among others.
Lowering barriers to adoption with digitalisation
Despite its benefits, widespread adoption of automation faces challenges. Only 10% of organisations have scaled their initiatives through effective automation. Barriers include high costs, perceived technological complexity and workforce turnover. Many labs struggle to recruit personnel skilled in both scientific and digital domains.
“Today’s lab operators expect drag-and-drop functionality, touchscreens and data analytics,” notes Magnan. Scalable systems allow labs to implement automation in phases, easing the transition for staff and spreading costs over time. AI and machine learning (ML) are becoming integral to lab automation. A recent survey revealed 68% of life science organisations are currently using AI and ML, up from 54% last year2. AI and ML are also cited as top technology investments over the next two years as investments in cloud platforms, electronic lab notebooks and laboratory information management systems are on the decline2.
The new Tecan VeyaTM platform exemplifies an integrated digital approach, consolidating workflow insights, system status and maintenance schedules into an intuitive OneViewTM interface. This user-centric design helps labs, especially those new to automation, transition smoothly from manual to automated processes.
The lab of the future balances automation and human expertise. By minimising manual tasks, scientists can focus on their specialised skills, accelerating innovation. Whether integrating AI-driven features or scalable automation solutions, Tecan can assist labs to define their goals and maximise the impact of these technologies.
Veya is not yet available for sale and performance claims are under ongoing verification and validation.
References:
- Global Lab Automation Market Size, Share, and COVID-19 Impact Analysis, By Lab Automation Equipment, By Application, and By Region, Analysis and Forecast 2023-2033, Spherical Insights (October 2024).
- Lab of the Future Survey 2024, The Pistoia Alliance (Sept. 25, 2024).
Learn more at www.tecan.com/veya
